Two projects for manufacturing fungicide active ingredients have advanced to trial production at Hailir subsidiary Qingdao Hengning Biotechnology, AgroPages reported on November 19. The move follows completion of the main construction work and equipment commissioning, as well as review and filing of the trial plan.
The projects have stated annual capacities of 6,000 tonnes for fluxapyroxad and 3,000 tonnes for bixafen. Both ingredients are in the SDHI fungicide group. The capacity figures describe the scale of the projects. AgroPages reported that the company expects production stability, output and quality to be evaluated as the trials proceed.
For suppliers and formulators tracking the fungicide supply chain, trial production and commercial availability are separate milestones. This announcement confirms entry into trials. It gives no date for reaching stable volumes, so the stated capacity is insufficient to estimate when additional supply might reach the market.
